New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - maprotiline hydrochloride 75mg;   - film coated tablet - 75 mg - active: maprotiline hydrochloride 75mg   excipient: calcium phosphate colloidal silicon dioxide hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc   stearic acid titanium dioxide - depression endogenous and late-onset (involutional) depression. psychogenic, reactive, and neurotic depression, exhaustion depression. somatogenic depression masked depression menopausal depression other depressive mood disorders characterised by anxiety, dysphoria, or irritability; apathetic states(especially in the elderly); psychosomatic and somatic symptoms with underlying depression and/or anxiety the diagnostic and statistical manual of mental disorders (dsm-iv-tr) and the international statistical classification of diseases and related health problems (icd-10) are standard classifications of mental disorders used by mental health professionals and describe the above mentioned disorders as follows: treatment of depressive episodes, recurrent depressive disorder or major depression.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - maprotiline hydrochloride - oral tablet - 75mg

Canada - English - Health Canada

novartis pharmaceuticals canada inc - maprotiline hydrochloride - tablet - 75mg - maprotiline hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

teva canada limited - maprotiline hydrochloride - tablet - 75mg - maprotiline hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - maprotiline hydrochloride 25mg;   - film coated tablet - 25 mg - active: maprotiline hydrochloride 25mg   excipient: calcium phosphate colloidal silicon dioxide hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc   stearic acid titanium dioxide - depression endogenous and late-onset (involutional) depression. psychogenic, reactive, and neurotic depression, exhaustion depression. somatogenic depression masked depression menopausal depression other depressive mood disorders characterised by anxiety, dysphoria, or irritability; apathetic states(especially in the elderly); psychosomatic and somatic symptoms with underlying depression and/or anxiety the diagnostic and statistical manual of mental disorders (dsm-iv-tr) and the international statistical classification of diseases and related health problems (icd-10) are standard classifications of mental disorders used by mental health professionals and describe the above mentioned disorders as follows: treatment of depressive episodes, recurrent depressive disorder or major depression.

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma-switzerland - coated tablet - 75 mg

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma-switzerland - coated tablet - 75 mg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sun pharma japan limited - maprotiline hydrochloride - white tablet, diameter: 6.1 mm. thickness: 3.1 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sun pharma japan limited - maprotiline hydrochloride - light yellow tablet, diameter: 6.1 mm. thickness: 3.1 mm